查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1851379

泡壳包装：市场占有率分析、产业趋势、统计数据和成长预测（2025-2030 年）

Blister Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2025 年，泡壳包装市场规模将达到 262.8 亿美元，到 2030 年将达到 326.8 亿美元，预测期内复合年增长率为 4.45%。

吸塑包装市场-IMG1

处方药、非处方药以及日益复杂的生技药品的强劲需求支撑着这一增长，同时，单剂量包装在医院、长期护理机构和零售渠道中持续取代大瓶装药品。监管压力，特别是欧盟第2025/40号法规（要求到2030年实现全面回收）和美国FDA加强的防篡改规定，正在推动一波合规主导的创新浪潮，在原材料成本波动的情况下，企业需要更高的定价和净利率保障。由于中国和印度的生产规模，亚太地区引领全球需求，而北美和欧洲则凭藉序列化、智慧包装和永续性升级，开闢了高价值的细分市场。同时，以安姆科以84.3亿美元收购贝瑞全球为代表的产业整合，标誌着业界正朝着灵活、稳健和智慧的整合解决方案转变，以服务跨国製药客户。

全球泡壳包装市场趋势与洞察

老年人口不断增加和慢性病盛行率上升

到2030年，全球60岁以上人口将激增56%，这将推动对易于使用的泡壳包装的需求，此类包装既能提高用药依从性，又能提供防篡改功能。像Drug Plastics Group这样的加工商正在将专为老年人设计的泡罩包装（例如更大的字体、颜色编码和更小的开启力度）商业化，其按压式封口设计可将所需的开启力度减少约四分之一。糖尿病和心血管疾病等慢性病也进一步推动了多剂量包​​装的普及，因为此类包装能够为复杂的用药方案提供清晰的视觉提示，并增强泡壳包装专家获得高价的动力。

单剂量包装和病人依从性包装的需求

医院、药局和居家医疗机构正日益将报销与用药依从性指标挂钩，这提升了泡壳包装单剂量製剂的重要性。 Parata 的自动化设备可直接与电子健康记录平台集成，减少配药错误，同时简化重新包装流程。 FDA 提议强制提案非处方速溶口腔崩坏药使用单剂量包装，凸显了监管机构对单剂量包装安全性的认可。製药品牌也正利用单剂量泡壳包装实现差异化，这种包装兼具品牌知名度和防篡改功能，是瓶装药品无法比拟的。

PVC和铝价格不稳定

中国计划于2025年将PVC进口关税从1%提高到5.5%，这增加了下游加工商的树脂成本，并凸显了它们对政策变化的脆弱性。印度加工商60%的PVC原料依赖进口，因此避险和后向整合是其风险管理的核心，它们仍然面临风险。此外，铝箔价格也随能源市场波动，对规模较小、无法签订多年合约的中小型泡壳企业带来压力。

细分市场分析

预计到2024年，热成型将占全球销售额的64.33%，年均成长率达5.67%。製药厂商青睐热成型製程低廉的模具成本、快速的生产线速度以及与多种薄膜基材的兼容性。博朗机械的Quad系列热成型机每小时可成型高达25万个封盖，同时能耗降低约四倍，从而提高合约包装商的生产效率，并延续泡壳包装市场的成长动能。 GEA推出的模组化设备如今也针对小型实验室开放，使供应商不再局限于大型跨国公司。

冷成型铝箔虽然市占率较小，但对于对水分和光敏感的分子而言仍然至关重要。当稳定性测试需要接近零水蒸气透过率时，药品製造商通常会指定使用铝-铝结构。随着生技药品和高效价成分的兴起，冷成型铝箔的应用基础不断扩大，推动了更薄铝箔和混合复合材料的研发，这些材料能够在不影响阻隔性的前提下减轻重量。这些进步共同拓展了该技术，并巩固了泡壳包装市场作为大批量学名药和利基特药通用包装平台的地位。

凭藉成熟的供应链和易于热成型的特性，包括PVC、PET和PP在内的塑胶薄膜将在2024年占据泡壳销售额的68.26%。然而，对化石基材料的日益严格的审查正在推动纸基解决方案的快速增长，预计到2030年将以7.34%的复合年增长率增长。 TekniPlex公司现已推出透明、可回收的中等阻隔PET泡壳，其再生材料含量高达30%，这充分展现了加工商如何在符合药典规范的同时，促进循环经济。

像Roller公司的EcoVolve-30这样的纸板参与企业，利用纤维和功能性涂层来承受生产线的高温，并保护片剂免受潮气侵蚀。虽然潮气敏感度限制了多种替代方案的选择，但品牌所有者正透过使用纸张包装维生素、营养补充剂和保质期较短的产品来提升其环保性。随着时间的推移，材料科学的突破有望使混合纤维-聚合物复合材料能够满足更高阻隔性性能的要求，从而推动泡壳包装市场规模的成长，并符合监管机构对再生材料含量的要求。

区域分析

到2024年，亚太地区将占全球收入的41.34%，以7.56%的复合年增长率超越其他所有地区。这主要得益于中国和印度扩大活性药物成分（API）生产规模并向西方品质标准接轨。药明康德在泰兴新建的API生产基地及其在新加坡的扩建计划，正是该地区製造地不断扩大的例证，直接推动了当地对符合标准的泡壳生产线的需求。中国将进口PVC关税提高至5.5%，将加强东亚泡壳包装市场供应链的在地化，并进一步促进国内薄膜挤出技术的发展。

北美依然是科技领域的领导者。美国食品药物管理局 (FDA) 严格的序列化和防篡改法规确保了智慧包装形式的高利润率，而生物製药的填充需求则推动了机械设备的投资。 PMMI 预测，到 2027 年，包装器材的销售额将达到历史新高，其中製药应用将超过食品饮料行业。安姆科收购贝瑞全球，将柔性包装和刚性包装的能力整合到一个平台，提供了北美小型加工商无法比拟的规模和垂直整合能力。

欧洲面临一些最严格的永续性法规。欧盟2025/40号法规强制要求PET包装到2030年实现可回收利用，且回收率达30%，这推动了对循环设计领域的投资。 TekniPlex公司透明、可回收的中等阻隔性泡壳包装展现了符合EMA严格阻隔性能规范的合规途径。临床试验包装也符合欧盟536/2014号法规的要求。 Catalent公司已在其位于日本滋贺县的工厂安装了一条高速泡壳线，以支持广泛地区试验，并凸显合规主导需求的全球性特征。因此，儘管材料选择不断变化，欧洲泡壳包装的市场份额仍然保持强劲。

其他福利：

  • Excel格式的市场预测（ME）表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 调查范围

第二章调查方法

第三章执行摘要

第四章 市场情势

  • 市场概览
  • 市场驱动因素
    • 老年人口不断增加和慢性病盛行率上升
    • 单剂量包装和病人依从性包装的需求
    • 加强对防篡改格式的监管
    • 智慧型泡壳包装，附NFC/QR码追踪功能
    • 个人化药品泡罩泡壳线
    • 永续性推动了PVC维修PE的需求。
  • 市场限制
    • PVC和铝价格不稳定
    • 加强对聚氯乙烯废弃物/回收的监管
    • PVDC树脂供应瓶颈
    • 非处方条状包装和袋装产品的替代品
  • 价值/供应链分析
  • 监管环境
  • 技术展望
  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争的激烈程度

第五章 市场规模与成长预测

  • 透过流程
    • 热成型
    • 冷成型
  • 材料
    • 塑胶薄膜（PVC、PET、PP、PE、rPET、COP 等）
    • 铝（铝铝箔，PTP箔）
    • 纸和纸板
  • 依产品类型
    • 卡片式/正面密封泡壳
    • 泡壳泡壳
    • 陷阱与全套卡片泡壳
    • 儿童安全/老人友善包装
  • 按最终用户行业划分
    • 製药
    • 营养补充品
    • 消费性电子产品和硬体
    • 个人护理和化妆品
    • 其他终端用户产业
  • 按地区
    • 北美洲
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 义大利
      • 西班牙
      • 俄罗斯
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 澳洲、纽西兰
      • 亚太其他地区
    • 中东和非洲
      • 中东
      • 阿拉伯聯合大公国
      • 沙乌地阿拉伯
      • 土耳其
      • 其他中东地区
      • 非洲
      • 南非
      • 奈及利亚
      • 埃及
      • 其他非洲地区
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章 竞争情势

  • 市场集中度
  • 策略趋势
  • 市占率分析
  • 公司简介
    • Amcor plc
    • WestRock Company
    • Constantia Flexibles GmbH
    • Klockner Pentaplast Group
    • Sonoco Products Company
    • DuPont de Nemours, Inc.
    • Honeywell International Inc.
    • Tekni-Plex, Inc.
    • Dow Inc.
    • Uflex Ltd.
    • Huhtamaki Oyj
    • Winpak Ltd.
    • Bilcare Ltd.
    • Bemis Company LLC（Amcor）
    • Lotte Aluminium Co., Ltd.
    • Toyo Aluminium KK
    • Pharma Packaging Solutions
    • R-Pharm Germany GmbH
    • FormPaks Ltd.
    • Zhejiang Hualian Pharmaceutical Co.

第七章 市场机会与未来展望

简介目录
Product Code: 50908

The blister packaging market size stands at USD 26.28 billion in 2025 and is set to climb to USD 32.68 billion by 2030, translating into a steady 4.45% CAGR over the forecast horizon.

Blister Packaging - Market - IMG1

Robust demand from prescription drugs, over-the-counter medications, and increasingly complex biologics underpins this growth, while unit-dose formats continue to displace bulk bottles across hospital, long-term-care, and retail channels. Regulatory pressure-most notably the European Union's Regulation 2025/40 mandating full recyclability by 2030 and the U.S. FDA's strengthened tamper-evident rules-has sparked a wave of compliance-driven innovation that commands premium pricing and protects margins even as raw-material costs fluctuate. Asia-Pacific leads global demand thanks to China and India's manufacturing scale, while North America and Europe shape high-value niches through serialization, smart packs, and sustainability upgrades. Meanwhile, industry consolidation-typified by Amcor's USD 8.43 billion purchase of Berry Global-signals a pivot toward integrated flexible, rigid, and intelligent solutions that can serve multinational pharmaceutical clients.

Global Blister Packaging Market Trends and Insights

Growing Geriatric Population and Chronic-Disease Prevalence

The global cohort aged 60 and above will surge 56% by 2030, intensifying demand for user-friendly blister packs that improve medication adherence while offering tamper evidence. Senior-centric designs-larger print, color coding, and low opening force-are being commercialized by converters such as Drug Plastics Group, whose Pop & Click closure reduces required hand pressure by roughly a quarter. Chronic conditions like diabetes and cardiovascular disease further amplify multi-dose pack adoption, enabling clear visual cues for complex regimes and reinforcing premium price realization for blister specialists.

Demand for Unit-Dose and Patient-Adherence Packs

Hospitals, pharmacies, and home-health providers increasingly link reimbursement to adherence metrics, elevating the role of blister-based unit-dose packs. Automated equipment from Parata now integrates directly with electronic health-record platforms, cutting dispensing errors while simplifying repack operations. The FDA's proposal to require single-unit containers for orally disintegrating OTC forms underscores regulatory endorsement of unit-dose safety benefits. Pharmaceutical brands also leverage unit-dose blisters for differentiation, combining brand visibility with tamper-evidence that bottles cannot replicate.

Volatile PVC and Aluminium Prices

China's jump in PVC import tariffs from 1% to 5.5% in 2025 lifted resin costs for downstream converters, spotlighting vulnerability to policy shifts. Indian converters remain exposed since 60% of their PVC feedstock is sourced abroad, making hedging and backward integration central to risk management. Aluminium foil prices also swing with energy markets, straining smaller blister firms that lack the scale to lock in multi-year contracts.

Other drivers and restraints analyzed in the detailed report include:

  1. Regulatory Push for Tamper-Evident Formats
  2. Smart Blister Packs with NFC/QR for Track-and-Trace
  3. Tightening PVC Disposal/Recycling Legislation

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Thermoforming commanded 64.33% of global revenues in 2024 and will grow 5.67% a year as drug makers favor its low tooling cost, fast line speeds, and compatibility with diverse film substrates. Brown Machine's Quad-Series thermoformers now deliver up to 250,000 lids per hour while trimming energy use by roughly one-quarter, giving contract packers productivity gains that sustain the blister packaging market's momentum. Smaller laboratories gain access through modular machines introduced by GEA, broadening supplier bases beyond large multinationals.

Cold-form foil, though a minority share, is indispensable for moisture- or light-sensitive molecules. Drug makers often specify aluminium-aluminium structures when stability studies demand near-zero water vapor transmission. As biologics and high-potency actives proliferate, cold form's installed base expands, intensifying R&D into thinner foils and hybrid lamination that cut weight without compromising barrier. Together, these advances widen the technology palette, reinforcing the blister packaging market as a versatile platform for both mass-production generics and niche specialty drugs.

Plastic films, led by PVC, PET, and PP, accounted for 68.26% of blister revenues in 2024 thanks to mature supply chains and easy thermoformability. Yet heightened scrutiny of fossil-based materials is spurring rapid incremental gains for paper-based solutions, which log a 7.34% CAGR through 2030. TekniPlex now offers transparent recyclable mid-barrier PET blisters containing 30% recycled content, illustrating how converters preserve pharmacopoeial compliance while advancing circularity.

Paperboard entrants such as Rohrer's EcoVolve-30 use fiber plus functional coatings to withstand line forming temperatures and protect moisture-tolerant tablets. Although moisture sensitivity limits broad substitution, brand owners deploy paper variants in vitamins, nutraceuticals, and short shelf-life SKUs, bolstering eco-credentials. Over time, material science breakthroughs are expected to let hybrid fiber-polymer laminates secure higher-barrier categories, reinforcing the blister packaging market size trajectory and aligning with regulatory recycled-content mandates.

The Blister Packaging Market Report is Segmented by Process (Thermoforming, Cold Forming), Material (Plastic Films, Aluminium, Paper and Paperboard), Product Type (Carded/Face-Seal Blisters, Clamshell Blisters, Trapped and Full-Card Blisters, and More), End-User Industry (Pharmaceuticals, Nutraceuticals and Dietary Supplements, and More), and Geography. The Market Forecasts are Provided in Terms of Value (USD).

Geography Analysis

Asia-Pacific led with 41.34% of 2024 revenue and will outpace all regions at 7.56% CAGR as China and India scale active-pharmaceutical-ingredient output and align with Western quality standards. WuXi STA's new Taixing API site and proposed Singapore expansion exemplify regional manufacturing build-out, directly lifting local demand for compliant blister lines. China's tariff hike on imported PVC to 5.5% further encourages domestic film extrusion, reinforcing supply-chain localization that underpins the blister packaging market in East Asia.

North America remains a technological bellwether. Stringent FDA serialization plus tamper-evidence rules sustain premium margins for intelligent formats, while machinery capex expands in anticipation of biologic fill-finish demand. PMMI projects packaging-machinery sales will hit record highs by 2027, with pharmaceutical applications outperforming food and beverage. Amcor's Berry Global acquisition consolidates flexible and rigid capabilities inside a single platform, ensuring scale and vertical reach that smaller North American converters will find hard to match.

Europe confronts the most aggressive sustainability legislation. Regulation 2025/40 enforces recyclability and 30% recycled content in PET packs by 2030, directing investment into circular-ready designs. TekniPlex's showcase of transparent recyclable mid-barrier blisters demonstrates compliance pathways that still satisfy stringent EMA barrier specifications. Clinical-trial packs also adapt to EU 536/2014, prompting Catalent to equip its Shiga, Japan, site with high-speed blister lines that serve pan-regional studies and underscore the global nature of compliance-driven demand. Consequently, the blister packaging market share in Europe remains resilient even as material choices evolve.

  1. Amcor plc
  2. WestRock Company
  3. Constantia Flexibles GmbH
  4. Klockner Pentaplast Group
  5. Sonoco Products Company
  6. DuPont de Nemours, Inc.
  7. Honeywell International Inc.
  8. Tekni-Plex, Inc.
  9. Dow Inc.
  10. Uflex Ltd.
  11. Huhtamaki Oyj
  12. Winpak Ltd.
  13. Bilcare Ltd.
  14. Bemis Company LLC (Amcor)
  15. Lotte Aluminium Co., Ltd.
  16. Toyo Aluminium K.K.
  17. Pharma Packaging Solutions
  18. R-Pharm Germany GmbH
  19. FormPaks Ltd.
  20. Zhejiang Hualian Pharmaceutical Co.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET LANDSCAPE

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Growing geriatric population and chronic-disease prevalence
    • 4.2.2 Demand for unit-dose and patient-adherence packs
    • 4.2.3 Regulatory push for tamper-evident formats
    • 4.2.4 Smart blister packs with NFC / QR for track-and-trace
    • 4.2.5 Personalized-medicine small-batch blister lines
    • 4.2.6 PVC-to-PE retrofit demand driven by sustainability
  • 4.3 Market Restraints
    • 4.3.1 Volatile PVC and aluminium prices
    • 4.3.2 Tightening PVC disposal / recycling legislation
    • 4.3.3 PVDC-resin supply bottlenecks
    • 4.3.4 OTC stick-pack and sachet substitution
  • 4.4 Value / Supply-Chain Analysis
  • 4.5 Regulatory Landscape
  • 4.6 Technological Outlook
  • 4.7 Porter's Five Forces Analysis
    • 4.7.1 Bargaining Power of Suppliers
    • 4.7.2 Bargaining Power of Buyers
    • 4.7.3 Threat of New Entrants
    • 4.7.4 Threat of Substitutes
    • 4.7.5 Intensity of Rivalry

5 MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1 By Process
    • 5.1.1 Thermoforming
    • 5.1.2 Cold Forming
  • 5.2 By Material
    • 5.2.1 Plastic Films (PVC, PET, PP, PE, rPET, COP, others)
    • 5.2.2 Aluminium (ALU-ALU, PTP foil)
    • 5.2.3 Paper and Paperboard
  • 5.3 By Product Type
    • 5.3.1 Carded / Face-Seal Blisters
    • 5.3.2 Clamshell Blisters
    • 5.3.3 Trapped and Full-Card Blisters
    • 5.3.4 Child-Resistant / Senior-Friendly Packs
  • 5.4 By End-User Industry
    • 5.4.1 Pharmaceuticals
    • 5.4.2 Nutraceuticals and Dietary Supplements
    • 5.4.3 Consumer Electronics and Hardware
    • 5.4.4 Personal Care and Cosmetics
    • 5.4.5 Other End-user Industry
  • 5.5 By Geography
    • 5.5.1 North America
      • 5.5.1.1 United States
      • 5.5.1.2 Canada
      • 5.5.1.3 Mexico
    • 5.5.2 Europe
      • 5.5.2.1 Germany
      • 5.5.2.2 United Kingdom
      • 5.5.2.3 France
      • 5.5.2.4 Italy
      • 5.5.2.5 Spain
      • 5.5.2.6 Russia
      • 5.5.2.7 Rest of Europe
    • 5.5.3 Asia-Pacific
      • 5.5.3.1 China
      • 5.5.3.2 India
      • 5.5.3.3 Japan
      • 5.5.3.4 South Korea
      • 5.5.3.5 Australia and New Zealand
      • 5.5.3.6 Rest of Asia-Pacific
    • 5.5.4 Middle East and Africa
      • 5.5.4.1 Middle East
      • 5.5.4.1.1 United Arab Emirates
      • 5.5.4.1.2 Saudi Arabia
      • 5.5.4.1.3 Turkey
      • 5.5.4.1.4 Rest of Middle East
      • 5.5.4.2 Africa
      • 5.5.4.2.1 South Africa
      • 5.5.4.2.2 Nigeria
      • 5.5.4.2.3 Egypt
      • 5.5.4.2.4 Rest of Africa
    • 5.5.5 South America
      • 5.5.5.1 Brazil
      • 5.5.5.2 Argentina
      • 5.5.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Market Concentration
  • 6.2 Strategic Moves
  • 6.3 Market Share Analysis
  • 6.4 Company Profiles (includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products and Services, and Recent Developments)
    • 6.4.1 Amcor plc
    • 6.4.2 WestRock Company
    • 6.4.3 Constantia Flexibles GmbH
    • 6.4.4 Klockner Pentaplast Group
    • 6.4.5 Sonoco Products Company
    • 6.4.6 DuPont de Nemours, Inc.
    • 6.4.7 Honeywell International Inc.
    • 6.4.8 Tekni-Plex, Inc.
    • 6.4.9 Dow Inc.
    • 6.4.10 Uflex Ltd.
    • 6.4.11 Huhtamaki Oyj
    • 6.4.12 Winpak Ltd.
    • 6.4.13 Bilcare Ltd.
    • 6.4.14 Bemis Company LLC (Amcor)
    • 6.4.15 Lotte Aluminium Co., Ltd.
    • 6.4.16 Toyo Aluminium K.K.
    • 6.4.17 Pharma Packaging Solutions
    • 6.4.18 R-Pharm Germany GmbH
    • 6.4.19 FormPaks Ltd.
    • 6.4.20 Zhejiang Hualian Pharmaceutical Co.

7 MARKET OPPORTUNITIES AND FUTURE OUTLOOK

  • 7.1 White-space and Unmet-need Assessment